Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:88406770
Filing Date:04/29/2019
NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular
application.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of a configuration of a medical device, namely, an inhaler with an overall rounded shape featuring an indented mouthpiece on the
top side with an overall semi-circular shape. The inhaler also features an exterior movable closure with an overall triangular shape, which rests towards the bottom and side of the inhaler when the
inhaler is opened. The indented mouthpiece is not claimed as a feature of the mark.
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
476 x 525
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Glaxo Group Limited
*STREET
980 Great West Road
*CITY
Brentford, Middlesex
*COUNTRY
England
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
TW89GS
LEGAL ENTITY INFORMATION
*TYPE
private company limited by shares (prc)
* STATE/COUNTRY WHERE LEGALLY ORGANIZED
England
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS
005
*IDENTIFICATION
Inhalers filled with pharmaceutical preparations for the treatment and alleviation of respiratory disorders
Photo image of actual packaging bearing the device
ADDITIONAL STATEMENTS SECTION
*TRANSLATION
(if applicable)
*TRANSLITERATION
(if applicable)
*CLAIMED PRIOR REGISTRATION
(if applicable)
*CONSENT (NAME/LIKENESS)
(if applicable)
*CONCURRENT USE CLAIM
(if applicable)
SECTION 2(f) Claim of Acquired Distinctiveness, based on Five or More Years' Use
The mark has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in
commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement.
ATTORNEY INFORMATION
NAME
Christopher M. Hanes
ATTORNEY DOCKET NUMBER
82774941
FIRM NAME
GSK
INTERNAL ADDRESS
LBP, 5.5A
STREET
5 Moore Drive
CITY
Research Triangle Park
STATE
North Carolina
COUNTRY
United States
ZIP/POSTAL CODE
27709-3398
PHONE
919-483-2723
FAX
919-315-3023
EMAIL ADDRESS
trademarks@gsk.com
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
OTHER APPOINTED ATTORNEY
Terence A. Dixon and Merilee J. Arevalo
CORRESPONDENCE INFORMATION
*NAME
Christopher M. Hanes
FIRM NAME
GSK
INTERNAL ADDRESS
LBP, 5.5A
*STREET
5 Moore Drive
*CITY
Research Triangle Park
*STATE
(Required for U.S. addresses)
North Carolina
*COUNTRY
United States
*ZIP/POSTAL CODE
27709-3398
PHONE
919-483-2723
FAX
919-315-3023
*EMAIL ADDRESS
trademarks@gsk.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Plus
NUMBER OF CLASSES
1
FEE PER CLASS
225
*TOTAL FEE PAID
225
SIGNATURE INFORMATION
* SIGNATURE
/Christopher M. Hanes/
* SIGNATORY'S NAME
Christopher M. Hanes
* SIGNATORY'S POSITION
Attorney of record, North Carolina bar member
SIGNATORY'S PHONE NUMBER
919-483-2723
* DATE SIGNED
04/29/2019
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
Serial Number:88406770
Filing Date:04/29/2019
To the Commissioner for Trademarks:
MARK: (Stylized and/or Design, see mark)
The applicant is not claiming color as a feature of the mark. The mark consists of a configuration of a medical device, namely, an inhaler with an overall rounded shape featuring an indented
mouthpiece on the top side with an overall semi-circular shape. The inhaler also features an exterior movable closure with an overall triangular shape, which rests towards the bottom and side of the
inhaler when the inhaler is opened. The indented mouthpiece is not claimed as a feature of the mark.
The applicant, Glaxo Group Limited, a private company limited by shares (prc) legally organized under the laws of England, having an address of
980 Great West Road
Brentford, Middlesex TW89GS
England
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005: Inhalers filled with pharmaceutical preparations for the treatment and alleviation of respiratory disorders
Use in Commerce: The applicant is using the mark in commerce on or in connection with the identified goods/services. The applicant attaches, or will later submit, one specimen as a JPG/PDF image file
showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, regardless of whether the mark itself is in the standard character format or is a
stylized or design mark. The specimen image file may be in color, and the image must be in color if color is being claimed as a feature of the mark.
In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee predecessor in interest at least as early as 10/31/2013, and first used in commerce
at least as early as 10/31/2013, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the
class of listed goods/services, consisting of a(n) Photo image of actual packaging bearing the device. Specimen File1
SECTION 2(f) Claim of Acquired Distinctiveness, based on Five or More Years' Use
The mark has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at
least the five years immediately before the date of this statement.
The applicant's current Attorney Information:
Christopher M. Hanes and Terence A. Dixon and Merilee J. Arevalo of GSK
LBP, 5.5A
5 Moore Drive
Research Triangle Park, North Carolina 27709-3398
United States
919-483-2723(phone)
919-315-3023(fax)
trademarks@gsk.com (authorized)
The attorney docket/reference number is 82774941.
The applicant's current Correspondence Information:
Christopher M. Hanes
GSK
LBP, 5.5A
5 Moore Drive
Research Triangle Park, North Carolina 27709-3398
919-483-2723(phone)
919-315-3023(fax)
trademarks@gsk.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Plus status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $225 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Christopher M. Hanes/ Date: 04/29/2019
Signatory's Name: Christopher M. Hanes
Signatory's Position: Attorney of record, North Carolina bar member
Signatory's Phone Number: 919-483-2723
Payment Sale Number: 88406770
Payment Accounting Date: 04/29/2019
Serial Number: 88406770
Internet Transmission Date: Mon Apr 29 11:51:31 EDT 2019
TEAS Stamp: USPTO/FTK-XXX.XX.XX.X-201904291151315987
37-88406770-620c195a428f57a188dab2bf8311
d5f8f4f596d1878d581b2cd26dbb63fcecf1c3-D
A-11407-20190428130715742237